Breast Cancer

SWOG S1416
NCI Sponsored
Phase II Randomized Placebo-controlled Trial of Cisplatin with or without ABT-888 (Veliparib) inMetastatic Triple Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
View on ClinicalTrials.gov
NRG-BR003
NCI
Sponsored
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
View on ClinicalTrials.gov
Alliance
A011401
NCI Sponsored

Breast Cancer WEight Loss Study (BWEL Study)
View on ClinicalTrials.gov

Advanced Colon Cancer

E7208
NCI
Sponsored
A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab, in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
View on ClinicalTrials.gov

Prostate Cancer

CK – 001
Industry
Sponsored
Virtual HDR CyberKnife Radiosurgery for Locally Recurrent Prostatic Carcinoma: a Phase II Study
View on ClinicalTrials.gov
RTOG 0924
NCI
Sponsored
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
View on ClinicalTrials.gov
   
For information about cancer clinical trials at AtlantiCare, please call the Oncology Clinical Research Coordinator, Kathryn A. Thomas, RN, BSN, OCN, CCRP at 609-677-7735.